Serum levels of soluble urokinase plasminogen activator receptor in juvenile idiopathic arthritis: a single-center Swedish case-control study
Abstract Objectives Reliable biomarkers in the early stages of idiopathic arthritis (JIA) are scarce and the disease heterogeneity makes it clinically challenging to predict the risk of joint damage. Biomarkers with prognostic potential are warranted in order to individualize treatment and follow-up...
Saved in:
Main Authors: | Per Lewander (Author), Lina Wirestam (Author), Charlotte Dahle (Author), Jonas Wetterö (Author), Christopher Sjöwall (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Soluble Urokinase Plasminogen Activator Receptor Levels in Resistant Hypertension
by: Nergiz Bayrakcı, et al.
Published: (2024) -
Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor
by: Viktor Rotbain Curovic, et al.
Published: (2022) -
Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
by: Dimitrios Velissaris, et al.
Published: (2022) -
Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects
by: Mohamed Abd‑Ellatif El‑Patal, et al.
Published: (2022) -
Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection
by: Sebastian M. Klim, et al.
Published: (2024)